Article Name Medtech innovation
Philips Secures FDA Clearance for Image-Guided Navigation Technology in Prostate Cancer Care
Breakthrough Minimally Invasive Solution Enhances Precision in Targeted Therapy Procedures, Supporting Improved Outcomes in Prostate Cancer Treatment
24th July, 2025
BD Launches First Pharma-Sponsored Trial Featuring Libertas™ Wearable Injector for Biologics
Clinical milestone underscores BD’s growing role in self-administered drug delivery and expands real-world evaluation of its on-body injection platform for large-volume biologics.
24th July, 2025
Natus Integrates Moberg CNS Monitor with NeuroWorks for Advanced EEG Capabilities
The integration enhances multimodal brain monitoring by streamlining EEG data access, visualization, and clinical decision-making in critical care environments.
23rd July, 2025
The FDA Is Phasing Out Animal Testing
As regulatory shifts accelerate, next-generation non-animal models must rapidly evolve to ensure safety, efficacy, and innovation in human drug development.
23rd July, 2025
Rebuilding the Drug Repurposing Pipeline with Better Data
How high-quality, integrated datasets are transforming drug repurposing from opportunistic discovery to systematic innovation in therapeutic development.
23rd July, 2025
Hesperos Unveils First Digital Twin of Human Disease with Organ-on-a-Chip Breakthrough
Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine.
23rd July, 2025
Canada Grants Patent to bioAffinity Technologies for CyPath® Lung Diagnostic Test
New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets
23rd July, 2025
Sutter Health Adopts Wearable Ultrasound to Optimize Sepsis Care
New AI-Enabled Technology Aims to Personalize Fluid Management and Improve Outcomes Across Hospital Network
23rd July, 2025
SkylineDx's Merlin Melanoma Assay Validated to Reduce Sentinel Lymph Node Biopsies by Over 40%
Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making
22nd July, 2025
Autonomix Medical Secures New U.S. Patent for Advancing Nerve-Targeted, Minimally Invasive Therapies
Patent strengthens company’s IP portfolio as it expands innovative treatments for chronic pain, oncology, and other high-need conditions
22nd July, 2025
Esperto Medical Wins Innovation Award for Pediatric Vital Sign Monitoring
Recognition highlights breakthrough technology designed to enhance continuous, child-friendly monitoring in clinical and home settings
22nd July, 2025
Takeda Secures FDA 510(k) Clearance for HyHub™ and HyHub™ Duo Devices
New devices designed to streamline and personalize HYQVIA® administration for patients receiving subcutaneous immune globulin therapy
22nd July, 2025
Medtronic Earns CE Mark for Expanded Use of MiniMed™ 780G Insulin Pump System
Approval now includes children as young as two, pregnant individuals, and people with type 2 diabetes across Europe
22nd July, 2025
Spirair Secures FDA Clearance for TurbAlign™ Bioabsorbable Nasal Implant
Innovative device designed to maintain sinus patency post-surgery, enhancing healing and patient comfort without the need for removal
22nd July, 2025
First U.S. Patient Enrolled in PRESERVE CAP Study for XVIVO Heart Assist Transport System
Pivotal trial launches to evaluate XVIVO’s portable perfusion device designed to optimize heart preservation and transplantation outcomes across the U.S.
21st July, 2025
Johnson & Johnson Unveils Global Insights on the Future of Surgical Software
New global report explores the transformative role of digital platforms, AI, and connectivity in reshaping surgical precision, training, and patient outcomes across healthcare systems.
21st July, 2025
Johnson & Johnson’s TAR-200 for Bladder Cancer Granted FDA Priority Review
NDA for TAR-200 targets high-risk non-muscle invasive bladder cancer, highlighting potential to transform treatment for patients unresponsive to BCG therapy
21st July, 2025
Texas Cardiac Arrhythmia Institute Becomes First in U.S. to Use FDA-Approved Wireless System for Arrhythmia Treatment
St. David's Medical Center pioneers clinical use of innovative wireless EP solution, marking a new chapter in minimally invasive cardiac care.
21st July, 2025
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer